US government to buy 100 million doses of COVID-19 trial vaccine

• The United States federal government is buying 100 million dosages of a COVID-19 vaccine prospect, it was revealed Tuesday.
• Under the arrangement, pharmaceutical business Moderna will manufacture the vaccine even as clinical trials are underway.
• The offer is worth approximately $1.5 billion. It also permits the US to acquire another 400 million dosages.
• See Organisation Insider’s homepage for more stories

The United States federal government has accepted pay up to $1.5 billion to obtain 100 million doses of a speculative COVID-19 vaccine, the Department of Health and Human Provider revealed Tuesday.

Under the deal, pharmaceutical business Moderna will make the dosages as it performs medical trials, which are anticipated to produce outcomes as early as October.

” Production in parallel with clinical trials accelerates the standard vaccine development timeline,” the HHS stated in a news release.

The vaccine has been co-developed by Moderna and the United States federal government’s National Institute of Allergic Reaction and Transmittable Illness.

” We appreciate the confidence of the US government in our mRNA vaccine platform and the continued assistance,” Moderna CEO Stéphane Bancel stated in a press release.

The offer is one of several that have actually been announced with vaccine manufacturers. As CNBC reported, the United States has provided up to $2.1 billion for a vaccine being developed by Sanofi and GlaxoSmithKline; another $1.

%%.

source https://jobsearchtips.net/us-government-to-buy-100-million-doses-of-covid-19-trial-vaccine/